Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial.

Stuart D. Russell; Paulina Selaru; David A. Pyne; Maha M. Ghazzi; Kenneth D. Massey; Milton Pressler; Alexis Serikoff; Andrew J. S. Coats

doi:10.1067/mhj.2003.39

Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial.

Stuart D. Russell, Paulina Selaru, David A. Pyne, Maha M. Ghazzi, Kenneth D. Massey, Milton Pressler, Alexis Serikoff, Andrew J. S. Coats

Faculty of Medicine and Health Sciences

Research output: Contribution to journal › Article

52 Citations (Scopus)

Original language	English
Pages (from-to)	179-186
Number of pages	8
Journal	American Heart Journal
Volume	145
Issue number	1
DOIs	https://doi.org/10.1067/mhj.2003.39
Publication status	Published - 2003

Access to Document

10.1067/mhj.2003.39

Cite this

Russell, Stuart D. ; Selaru, Paulina ; Pyne, David A. ; Ghazzi, Maha M. ; Massey, Kenneth D. ; Pressler, Milton ; Serikoff, Alexis ; Coats, Andrew J. S. / Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial. In: American Heart Journal. 2003 ; Vol. 145, No. 1. pp. 179-186.

@article{6295085b4e2347398f0ba02783501b05,

title = "Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial.",

author = "Russell, {Stuart D.} and Paulina Selaru and Pyne, {David A.} and Ghazzi, {Maha M.} and Massey, {Kenneth D.} and Milton Pressler and Alexis Serikoff and Coats, {Andrew J. S.}",

year = "2003",

doi = "10.1067/mhj.2003.39",

language = "English",

volume = "145",

pages = "179--186",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

number = "1",

}

Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial. / Russell, Stuart D.; Selaru, Paulina; Pyne, David A.; Ghazzi, Maha M.; Massey, Kenneth D.; Pressler, Milton; Serikoff, Alexis; Coats, Andrew J. S.

In: American Heart Journal, Vol. 145, No. 1, 2003, p. 179-186.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin Antagonist in CHF patients undergoing Exercise) trial.

AU - Russell, Stuart D.

AU - Selaru, Paulina

AU - Pyne, David A.

AU - Ghazzi, Maha M.

AU - Massey, Kenneth D.

AU - Pressler, Milton

AU - Serikoff, Alexis

AU - Coats, Andrew J. S.

PY - 2003

Y1 - 2003

U2 - 10.1067/mhj.2003.39

DO - 10.1067/mhj.2003.39

M3 - Article

VL - 145

SP - 179

EP - 186

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -